C
Caterina Gozzoli
Researcher at Catholic University of the Sacred Heart
Publications - 65
Citations - 685
Caterina Gozzoli is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Medicine & Prison. The author has an hindex of 14, co-authored 60 publications receiving 491 citations. Previous affiliations of Caterina Gozzoli include University of Milan & The Catholic University of America.
Papers
More filters
Journal ArticleDOI
Longitudinal Survey of Fungi in the Human Gut: ITS Profiling, Phenotyping, and Colonization.
Stefano Raimondi,Alberto Amaretti,Caterina Gozzoli,Marta Simone,Lucia Righini,Francesco Candeliere,Paola Brun,Andrea Ardizzoni,Bruna Colombari,Simona Paulone,Ignazio Castagliuolo,Duccio Cavalieri,Elisabetta Blasi,Maddalena Rossi,Samuele Peppoloni +14 more
TL;DR: Results confirm the allochthonous nature of most the intestinal fungi, while C. albicans appears to be commonly involved in stable colonization.
Journal ArticleDOI
Profiling of Protein Degraders in Cultures of Human Gut Microbiota.
Alberto Amaretti,Caterina Gozzoli,Marta Simone,Stefano Raimondi,Lucia Righini,Vicente Pérez-Brocal,Rodrigo García-López,Andrés Moya,Maddalena Rossi +8 more
TL;DR: Light is shed on the multitude of bacterial taxa putatively participating in protein catabolism in the colon, due to both the production of toxic metabolites and the blooming of opportunistic pathogens and pro-inflammatory bacteria.
Journal ArticleDOI
The social relevance and social impact of knowledge and knowing
TL;DR: In recent years, there has been a growing concern around the connection between theory and practice, rigour and relevance, theoretical consistency and impact as mentioned in this paper, and the importance of theoretical consistency.
Journal ArticleDOI
Conjugated Linoleic Acid Production by Bifidobacteria: Screening, Kinetic, and Composition
Stefano Raimondi,Alberto Amaretti,Alan Leonardi,Andrea Quartieri,Caterina Gozzoli,Maddalena Rossi +5 more
TL;DR: Production and incorporation of CLA in biomass were assessed for the first time, and the strain B. breve WC 0421 was the best CLA producer, converting LA into 68.8% 9cis,11trans-CLA and 25.1% 9trans,11 trans-CLA.
Journal ArticleDOI
The probiotic Bifidobacterium breve B632 inhibited the growth of Enterobacteriaceae within colicky infant microbiota cultures.
Marta Simone,Caterina Gozzoli,Andrea Quartieri,Giuseppe Mazzola,Diana Di Gioia,Alberto Amaretti,Stefano Raimondi,Maddalena Rossi +7 more
TL;DR: The results support the possibility to move to another level of study, that is, the administration of B. breve B632 to a cohort of colicky newborns, in order to observe the behavior of this strain in vivo and to validate its effect in colic treatment.